HYPOCHOLESTEROLEMIC AGENT

FIELD: medicine, pharmacy. SUBSTANCE: invention relates to pharmaceutical preparations and can be used in treatment of hypercholesterolemia (primary, in combination with hypertriglyceridemia), atherosclerosis. Invention involves the use of lovastatin as active component and microcrystalline cellulos...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DZABAEVA S.M, SUL'DIN A.V, BEKTEMIROV A.A, PARKANSKIJ A.A, KRIVOSHEEV S.A
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, pharmacy. SUBSTANCE: invention relates to pharmaceutical preparations and can be used in treatment of hypercholesterolemia (primary, in combination with hypertriglyceridemia), atherosclerosis. Invention involves the use of lovastatin as active component and microcrystalline cellulose, starch, modified starch or croscarmellose, stearic acid or its salts, butyloxyanisol and lactose as accessory components taken in the definite ratio of components. Invention provides stability of drug in storage for all time of preparation fitness. EFFECT: enhanced effectiveness of agent. 4 cl